Characterization of a long isoform of IL-1R8 (TIR8/SIGIRR)

European Cytokine Network

Volumn 28, Issue 2, 2017, Pages 63-69

  Vilia, Maria Giovanna ^a   Tocchetti, Marta ^a   Fonte, Eleonora ^a   Sana, Ilenia ^a   Muzio, Marta ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

IL 1R8; Interleukin 1 receptor; SIGIRR; Splicing; TIR8; Toll like receptor

Indexed keywords

INTERLEUKIN 1 RECEPTOR; ISOPROTEIN; MESSENGER RNA; SIGIRR PROTEIN, HUMAN;

ALTERNATIVE RNA SPLICING; CELL LINE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOLECULAR CLONING; SIGNAL TRANSDUCTION;

ALTERNATIVE SPLICING; CELL LINE; CLONING, MOLECULAR; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HUMANS; PROTEIN ISOFORMS; RECEPTORS, INTERLEUKIN-1; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 85026860035     PISSN: 11485493     EISSN: 19524005     Source Type: Journal    
DOI: 10.1684/ecn.2017.0395     Document Type: Article

References (30)

1. Whitham S, Dinesh-Kumar SP, Choi D, Hehl R, Corr C, Baker B. The product of the tobacco mosaic virus resistance gene N: similarity to toll and the interleukin-1 receptor. Cell 1994; 78: 1101-15.
2. O’Neill LAJ, Golenbock D, Bowie AG. The history of Tolllike receptors, redefining innate immunity. Nat Rev Immunol 2013; 13: 453-60.
3. Garlanda C, Dinarello CA, Mantovani A. The interleukin-1 family: back to the future. Immunity 2013; 39: 1003-18.
4. Warner N, Núnez G. MyD88: a critical adaptor protein in innate immunity signal transduction. J Immunol 2013; 190: 3-4.
5. O’Neill LAJ. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol Rev 2008; 226: 10-8.
6. Garlanda C, Riva F, Bonavita E, Mantovani A. Negative regulatory receptors of the IL-1 family. Semin Immunol 2013; 25: 408-15.
7. Riva F, Bonavita E, Barbati E, Muzio M, Mantovani A, Garlanda C. TIR8/SIGIRR is an Interleukin-1 Receptor/Toll like receptor family member with regulatory functions in inflammation and immunity. Front Immunol 2012; 3: 322.
8. Thomassen E, Renshaw BR, Sims JE. Identification and characterization of SIGIRR, a molecule representing a novel subtype of the IL-1R superfamily. Cytokine 1999; 11: 389-99.
9. Polentarutti N, Rol GP, Muzio M, Bosisio D, Camnasio M, Riva F, et al. Unique pattern of expression and inhibition of IL-1 signaling by the IL-1 receptor family member TIR8/SIGIRR. Eur Cytokine Netw 2003; 14: 211-8.
10. Qin J, Qian Y, Yao J, Grace C, Li X. SIGIRR inhibits interleukin-1 receptor-and toll-like receptor 4-mediated signaling through different mechanisms. J Biol Chem 2005; 280: 25233-41.
11. Feng T, Yunfeng N, Jinbo Z, Zhipei Z, Huizhong Z, Li L, et al. Single immunoglobulin IL-1 receptor-related protein attenuates the lipopolysaccharide-induced inflammatory response in A549 cells. Chem Biol 2010; 183: 442-9.
12. Lech M, Skuginna V, Kulkarni OP, Gong J, Wei T, Stark RW, et al. Lack of SIGIRR/TIR8 aggravates hydrocarbon oil-induced lupus nephritis. J Pathol 2010; 220: 596-607.
13. Gong J, Wei T, Stark RW, Jamitzky F, Heckl WM, Anders HJ, et al. Inhibition of Toll-like receptors TLR4 and 7 signaling pathways by SIGIRR: a computational approach. J Struct Biol 2010; 169: 323-30.
14. Bertilaccio MTS, Simonetti G, Dagklis A, Rocchi M, Rodriguez TV, Apollonio B, et al. Lack of TIR8/SIGIRR triggers progression of chronic lymphocytic leukemia in mouse models. Blood 2011; 118: 660-9.
15. Garlanda C, Riva F, Veliz T, Polentarutti N, Pasqualini F, Radaelli E, et al. Increased susceptibility to colitis-associated cancer of mice lacking TIR8, an inhibitory member of the interleukin-1 receptor family. Cancer Res 2007; 67: 6017-21.
16. Xiao H, Gulen MF, Qin J, Yao J, Bulek K, Kish D, et al. The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. Immunity 2007; 26: 461-75.
17. Costelloe C, Watson M, Murphy A, McQuillan K, Loscher C, Armstrong ME, et al. IL-1F5 mediates anti-inflammatory activity in the brain through induction of IL-4 following interaction with SIGIRR/TIR8. J Neurochem 2008; 105: 1960-9.
18. Lunding L, Webering S, Vock C, Schröder A, Raedler D, Schaub B, et al. IL-37 requires IL-18R_ and SIGIRR/IL-1R8 to diminish allergic airway inflammation in mice. Allergy 2015; 70: 366-73.
19. Nold-Petry CA, Lo CY, Rudloff I, Elgass KD, Li S, Gantier MP, et al. IL-37 requires the receptors IL-18R_ and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction. Nat Immunol 2015; 16: 354-65.
20. Li S, Neff CP, Barber K, Hong J, Luo Y, Azam T, et al. Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8. Proc Natl Acad Sci U S A 2015; 112: 2497-502.
21. Zhao J, Bulek K, Gulen MF, Zepp JA, Karagkounis G, Martin BN, et al. Human colon tumors express a dominant-negative form of SIGIRR that promotes inflammation and colitis-associated colon cancer in mice. Gastroenterology 2015; 149: 1860-8.
22. Clark HF, Gurney AL, Abaya E, Baker K, Baldwin D, Brush J, et al. The secreted protein discovery initiative (SPDI), a largescale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. Genome Res 2003; 13: 2265-70.
23. Vilia MG, Fonte E, Véliz Rodriguez T, Tocchetti M, Ranghetti P, Scarfò L, et al. The inhibitory receptor toll interleukin-1R 8 (TIR8/IL-1R8/SIGIRR) is downregulated in chronic lymphocytic leukemia. Leuk Lymphoma 2017: 1-7.
24. Kadota C, Ishihara S, Aziz MM, Rumi MA, Oshima N, Mishima Y, et al. Down-regulation of single immunoglobulin interleukin-1R-related molecule (SIGIRR)/TIR8 expression in intestinal epithelial cells during inflammation. Clin Exp Immunol 2010; 162: 348-61.
25. Molgora M, Barajon I, Mantovani A, Garlanda C. Regulatory role of IL-1R8 in immunity and disease. Front Immunol 2016; 7: 917-1015.
26. Biamonti G, Catillo M, Pignataro D, Montecucco A, Ghigna C. The alternative splicing side of cancer. Semin Cell Dev Biol 2014; 32: 30-6.
27. Penton-Rol G, Orlando S, Polentarutti N, Bernasconi S, Muzio M, Introna M, et al. Bacterial lipopolysaccharide causes rapid shedding, followed by inhibition of mRNA expression, of the IL-1 type II receptor, with concomitant up-regulation of the type I receptor and induction of incompletely spliced transcripts. J Immunol 1999; 162: 2931-8.
28. Jensen LE, Muzio M, Mantovani A, Whitehead AS. IL-1 signaling cascade in liver cells and the involvement of a soluble form of the IL-1 receptor accessory protein. J Immunol 2000; 164: 5277-86.
29. Andre R, Wheeler RD, Collins PD, Luheshi GN, Pickering-Brown S, Kimber I, et al. Identification of a truncated IL-18R beta mRNA: a putative regulator of IL-18 expressed in rat brain. J Neuroimmunol 2003; 145: 40-5.
30. Smith DE, Lipsky BP, Russell C, Ketchem RR, Kirchner J, Hensley K, et al. A central nervous system-restricted isoform of the interleukin-1 receptor accessory protein modulates neuronal responses to interleukin-1. Immunity 2009; 30: 817-31.